Nordic Bioscience Investor
Nordic Bioscience is dedicated to preclinical and clinical drug development, specializing in personalized medicine using unique biomarker.
Industry:
Omic
Headquarters:
Herlev, Hovedstaden, Denmark
Founded Date:
1991-01-01
Employees Number:
51-100
Funding Status:
Private Equity
Number Of Exits:
1
Investors Number:
1
Total Funding:
100000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-03-03
Last Funding Type:
Private Equity
Register and Claim Ownership